Matches in Wikidata for { <http://www.wikidata.org/entity/Q94428880> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q94428880 description "article scientifique publié en 2019" @default.
- Q94428880 description "wetenschappelijk artikel" @default.
- Q94428880 description "наукова стаття" @default.
- Q94428880 name "SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome" @default.
- Q94428880 name "SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome" @default.
- Q94428880 type Item @default.
- Q94428880 label "SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome" @default.
- Q94428880 label "SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome" @default.
- Q94428880 prefLabel "SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome" @default.
- Q94428880 prefLabel "SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome" @default.
- Q94428880 P1433 Q94428880-1C1A6D83-E984-4238-8EC8-A93E02631A1D @default.
- Q94428880 P1476 Q94428880-98146ADF-F7B4-450C-BF68-D9C1573F62E1 @default.
- Q94428880 P2093 Q94428880-0DCCF81D-84C6-462D-A786-6AEFCB9D3976 @default.
- Q94428880 P2093 Q94428880-3AAA32ED-FC22-4F89-AA6E-FF4094E55CB7 @default.
- Q94428880 P2093 Q94428880-47B85418-577A-4916-B1DC-423FCBEA5582 @default.
- Q94428880 P2093 Q94428880-792E00A9-24AA-480C-9908-8564AD0D3CCD @default.
- Q94428880 P2093 Q94428880-A49AB33D-4AC3-4A58-AAD5-4147B0702331 @default.
- Q94428880 P2093 Q94428880-A5ED32DD-E454-428E-AECA-487A0ECA746D @default.
- Q94428880 P2093 Q94428880-A7E3F6CD-D4C6-4AA1-91B5-D63591BBE829 @default.
- Q94428880 P275 Q94428880-d35aeea6-48da-4f3e-9773-fd7a00dbc7b7 @default.
- Q94428880 P31 Q94428880-24BD38CE-FE7F-49AD-93C5-7BA6653E85A8 @default.
- Q94428880 P356 Q94428880-5DF31D49-F8F1-4DCE-B6AB-A2ADDD715A68 @default.
- Q94428880 P433 Q94428880-1E157B7D-65D4-434D-86E6-C7D8B0EB7623 @default.
- Q94428880 P478 Q94428880-FB89A862-9593-4088-9A26-6244DE3783F1 @default.
- Q94428880 P577 Q94428880-A8843C53-92A1-4204-83D6-B75659B374DF @default.
- Q94428880 P6216 Q94428880-aaafebe8-e5ff-404a-acb5-fd11368c393e @default.
- Q94428880 P921 Q94428880-548AE0CF-C331-4F2A-AC9F-015CE8820DDB @default.
- Q94428880 P921 Q94428880-799A8D3E-E906-4E1A-A618-C6F0C8A020D2 @default.
- Q94428880 P932 Q94428880-B644DB65-F369-4C49-9F1E-1676CF56B616 @default.
- Q94428880 P356 JS.2019-SAT-100 @default.
- Q94428880 P1433 Q50817780 @default.
- Q94428880 P1476 "SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome" @default.
- Q94428880 P2093 "Maithe Tauber" @default.
- Q94428880 P2093 "Michael Yeh" @default.
- Q94428880 P2093 "Nadege Tremel" @default.
- Q94428880 P2093 "Pharis Mohideen" @default.
- Q94428880 P2093 "Soraya Allas" @default.
- Q94428880 P2093 "Thomas Delale" @default.
- Q94428880 P2093 "Vivian Lin" @default.
- Q94428880 P275 Q24082749 @default.
- Q94428880 P31 Q13442814 @default.
- Q94428880 P356 "10.1210/JS.2019-SAT-100" @default.
- Q94428880 P433 "Suppl 1" @default.
- Q94428880 P478 "3" @default.
- Q94428880 P577 "2019-04-30T00:00:00Z" @default.
- Q94428880 P6216 Q50423863 @default.
- Q94428880 P921 Q269829 @default.
- Q94428880 P921 Q594013 @default.
- Q94428880 P932 "6552513" @default.